Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eldorado Resorts, Sundial, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm
October 09, 2019 12:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Eldorado Resorts, Inc....
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eldorado Resorts, Sundial, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm
October 02, 2019 21:12 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Eldorado Resorts, Inc....
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 25, 2019 11:05 ET
|
Schall Law
LOS ANGELES, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 18, 2019 11:30 ET
|
Schall Law
LOS ANGELES, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 11, 2019 09:27 ET
|
Schall Law
LOS ANGELES, Sept. 11, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 04, 2019 11:20 ET
|
Schall Law
LOS ANGELES, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 28, 2019 10:20 ET
|
Schall Law
LOS ANGELES, Aug. 28, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 23, 2019 11:02 ET
|
Schall Law
LOS ANGELES, Aug. 23, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad...
Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.
June 04, 2018 17:37 ET
|
Federman & Sherwood
OKLAHOMA CITY, June 04, 2018 (GLOBE NEWSWIRE) -- On April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of Utah against Myriad Genetics, Inc....
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc.
April 24, 2018 17:18 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., April 24, 2018 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Myriad Genetics, Inc. (NASDAQ:MYGN)? Did you purchase your shares between August...